{"name": "pemafibrate", "category": "drug", "content": "Pemafibrate, sold under the brand namd Parmodia, is a peroxisome proliferator-activated receptor alpha (PPAR\u03b1) agonist. It is developed and marketed by Kowa Pharmaceuticals. In July 2017, Pharmaceuticals and Medical Devices Agency approved it in Japan.   == References =="}